Triglyceride and composition comprising the same
AssigneeSuntory Limited
InventorsKengo Akimoto, Toshiaki Yaguchi, Shigeaki Fujikawa
Life of this patent
Estimating the term…
Abstract
The present invention provides a novel triglyceride and a composition containing that novel triglyceride having a triglyceride structure of the human breast milk type, which triglyceride has a saturated fatty acid having 16-18 carbon atoms at the position 2, at the position 1 and/or 3; which is and at least one ω6, ω9 or ω3 unsaturated fatty acid manufactured by subjecting a glyceride in which a saturated fatty acid having 16 to 18 carbon atoms is bonded at position 2 to transesterification using a lipase and a ω6, ω9 or ω3-unsaturated fatty acid.
Claims22
A triglyceride represented by the following general formula (I):
- wherein R1 and R2 are acyl groups, which may be oxidised, of unsaturated fatty acids having from 18 to 22 carbon atoms, n represents an integer from 14 to 16, at least one of R1 and R2 is ω6-, ω9-, or ω3-unsaturated fatty acid, but excluding those triglycerides in which
- (i) when n is 14:
- R1 and R2 are both eicosapentaenoate:
- R1 and R2 are both docosahexaenoate:
- R1 and R2 are both linolenate:
- R1 is linoleate and R2 is linolenate:
- R1 is eicosapentaenoate and R2 is docosahexaenoate:
- (ii) when n is 16, R1 is docosahexaenoate and R2 is docosahexaenoate or 22:5 ω3.
A triglyceride represented by the following general formula (II):
- wherein R3 represents an acyl group, which may be oxidised, of ω6-, ω9- or ω3-unsaturated fatty acid having from 18 to 22 carbon atoms, n represents an integer from 14 to 16, and m represents an integer from 2 to 16, but excluding those triglycerides in which
- (i) when n and m are both 14, R3 is eicosapentaenoate, linolenate or linoleate;
- (ii) when n and m are both 16, R3 is linoleate.
A triglyceride represented by the following general formula (I):
- wherein R1 and R2 are acyl groups, which may be oxidised, of unsaturated fatty acids having from 18 to 22 carbon atoms, n represents an integer from 14 to 16, at least one of R1 and R2 is selected from the group consisting of:
- 8,11,14-eicosatrienoic acid (dihomo-γ-linolenic acid) 20:3, ω6
- 5,8,11,14-eicosatetraenoic acid (arachidonic acid) 20:4, ω6
- 7,10,13,16-docosatetraenoic acid 22:4, ω6
- 6,9-octadecadienoic acid 18:2, ω9
- 8,11-eicosadienoic acid 20:2, ω9
- 5,8,11-eicosatrienoic acid (Mead acid) 20:3, ω9
- 9,12,15-octadecatrienoic acid (α-linolenic acid) 18:3, ω3
- 6,9,12,15-octadecatetraenoic acid (stearidonic acid) 18:4, ω3
- 11,14,17-eicosatrienoic acid (dihomo-α-linolenic acid) 20:3, ω3
- 8,11,14,17-eicosatetraenoic acid 20:4, ω3
- 5,8,11,14,17-eicosapentaenoic acid 20:5, ω3 and
- 7,10,13,16,19-docosapentaenoic acid 22:5, ω3.
Dependencies are inferred from the claim text.